TNF Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
TNF Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • TNF Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.37M, a 41.7% increase year-over-year.
  • TNF Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$14.9M, a 6.2% increase year-over-year.
  • TNF Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$17.1M, a 12% decline from 2022.
  • TNF Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$15.3M, a 47% increase from 2021.
  • TNF Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$28.8M, a 204% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$17.1M -$1.84M -12% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$15.3M +$13.5M +47% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$28.8M -$19.3M -204% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$9.49M -$6.02M -173% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$3.47M +$6.59M +65.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$10.1M -$3.45M -52.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 -$6.61M -$3.29M -98.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$3.33M +$6.35M +65.6% Jan 1, 2016 Dec 31, 2016 10-K/A 2018-07-13
2015 -$9.68M -$6.48M -202% Jan 1, 2015 Dec 31, 2015 10-K 2017-04-11
2014 -$3.2M -$1.39M -77% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 -$1.81M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.